Discover trends, market shifts, and competitive outlooks for the immunohematology industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has the Immunohematology Market Growth Performance Trended Historically, And What Lies Ahead?#_x000D_

In the past few years, the size of the immunohematology market has seen a consistent increase. It is expected to expand from $2.46 billion in 2024 to $2.57 billion in 2025, experiencing a compound annual growth rate (CAGR) of 4.6%. This growth during the historical period can be associated with the progress in blood transfusion technology, the rising occurrence of blood ailments, enlargement of blood banks, government-led initiatives for ensuring the safety of blood, the surge in surgical procedures, and heightened awareness about the hazards related to transfusions._x000D_

_x000D_

Expectations are high for significant expansion in the immunohematology market in the upcoming years. The projected size of the market is anticipated to reach “$3.24 billion by 2029, witnessing a compound annual growth rate (CAGR) of 5.9%. This anticipated growth over the forecast period can be ascribed to various factors such as the rising demand for point-of-care testing, emergence of new blood products, development of healthcare infrastructure, genetic testing for determining blood compatibility, and stringent regulation for ensuring blood safety. The forecast period is likely to see major trends like the incorporation of automation and high-throughput systems, use of molecular blood typing methods, advent of antibody detection techniques, prioritization of patient blood management programs, and the integration of artificial intelligence in analysis along with telemedicine._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp_x000D_

_x000D_

#What External and Internal Drivers Are Contributing to the Growth of theImmunohematology Market?#_x000D_

The anticipated increase in hematological disorders is predicted to stimulate the expansion of the immunohematology market in the future. These are varying conditions that influence the blood and its components such as red blood cells, white blood cells, plasma, and platelets. Immunohematology plays a crucial role in ensuring blood transfusions are safe and effective by preventing reactions that may occur due to incompatible blood types or the presence of antibodies in the recipient’s blood. It also employs techniques for diagnosing and treating diseases related to the immune system which might affect the system of blood. For example, Cancer Research UK, a research organization based in the UK, has projected that the average number of new cases of leukemia triggered by hematological disorders will rise from an estimated 12,400 cases in 2023-2025 to approximately 14,500 cases in 2038-2040. Consequently, the rising rate of hematological disorders’ prevalence is fueling the growth of the immunohematology market._x000D_

_x000D_

#What Segment Types Define the Immunohematology Market Structure?#_x000D_

The immunohematology market covered in this report is segmented –_x000D_

_x000D_

1) By Product: Analyzers And Systems, Reagents_x000D_

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)_x000D_

3) By Disease: Blood-Related Diseases, HIV, Hepatitis_x000D_

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology_x000D_

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes_x000D_

_x000D_

Subsegments:_x000D_

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems_x000D_

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Immunohematology Market?#_x000D_

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#What Long-Term Trends Are Transforming the Competitive Landscape of the Immunohematology Market?#_x000D_

Leading businesses in the immunohematology field are concentrating on creating innovative diagnostic aids such as soluble recombinant proteins, developed to counteract the disturbance caused by the cancer treatment daratumumab. These proteins, manufactured via recombinant DNA technology, remain functional and correctly folded in a soluble format in a host cell or liquid, assisting their use in research and medical settings. Grifols, S.A., a pharmaceutical firm based in Spain, for instance, in November 2023, unveiled the Grifols sCD38 solution. This is the inaugural soluble recombinant protein produced by Grifols, designed to deal with the interference created by the daratumumab cancer therapy during crucial blood transfusion compatibility testing. It is specifically created for multiple myeloma patients, this revolutionary solution prevents daratumumab from adhering to CD38 proteins on red blood cells, ensuring accurate pre-transfusion test results. The Grifols sCD38 improves blood transfusion procedures and reduces delays in supplying crucial transfusions by allowing a more streamlined process for screening, identifying, and cross-matching._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report_x000D_

_x000D_

#What Is the Definition of the Immunohematology Market?#_x000D_

Immunohematology is a branch of laboratory medicine that studies blood groups and the body’s immune response to foreign substances, particularly in blood transfusions. Immune hematological techniques are used to locate and address diagnostic issues in patients with hematological conditions, such as auto-immune hemolytic anemia._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10295_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model